Intravitreal bevacizumab for ROP in Guatemala

Ana L. Asturias, Roberto Jule,Joaquin Barnoya

Journal of Aapos（2017）

引用 0|浏览6

暂无评分

摘要

Laser therapy can be ineffective and challenging for stage 3 retinopathy of prematurity (ROP). Bevacizumab can be an alternative treatment. This study aims to compare outcomes and costs of laser and Bevacizumab for ROP treatment in Guatemala, a low-resource setting.

查看译文

关键词

intravitreal bevacizumab,guatemala

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要